<DOC>
	<DOCNO>NCT02312401</DOCNO>
	<brief_summary>The purpose study well understand prostate cancer change radiation treatment , magnetic resonance imaging ( MRI ) . MRI image test allow doctor see prostate gland without operation procedure . It help identify tumor prostate . For patient newly diagnose prostate cancer , MRI may help doctor manage treatment good sooner .</brief_summary>
	<brief_title>Evaluation Treatment Response Using Multiparametric MRI After Prostate Radiotherapy</brief_title>
	<detailed_description />
	<criteria>Patients biopsy proven ( complete and/or review MSK ) adenocarcinoma prostate , undergo external beam radiotherapy use conventional fractionation IGRT , low rate brachytherapy alone , low dose rate brachytherapy combine IGRT , SBRT , proton radiotherapy . Age â‰¥ 18 year old Baseline MPMRI , obtain MSKCC Main Campus 3Tesla Philips MRI unit part standard ( clinical ) stag assessment demonstrates least one dominant visible lesion measure &gt; 0.5 cm maximum axial diameter assess T2weighted image . No prior history androgen deprivation therapy within last month . However patient receive neoadjuvant concurrent adjuvant hormonal therapy eligible . Willing come MSK Main Campus baseline followup MPMRIs . History radical prostatectomy Patients unwilling unable undergo MRI include patient contraindication MRI presence cardiac pacemaker noncompatible intracranial vascular clip , claustrophobia , inability lie flat duration study etc . Patients metallic hip implant , metallic implant device pelvis ferromagnetic fiducial beacon ( Calypso ) might distort local magnetic field compromise quality MPMRI Patients gadolinium contrast contraindicate . Metastatic disease</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>MRI</keyword>
	<keyword>14-172</keyword>
</DOC>